Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haiyang Tang

Showing results (121-130 of 152) with videos related to

Pageof 16
Sort By:
Hypertension (Dallas, Tex. : 1979)|November 8, 2022
The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary HypertensionChanglei Bao, Shuxin Liang, Ying Han, et al.
International Journal of Molecular Sciences|December 11, 2022
Sphingosine Kinase 1 Deficiency in Smooth Muscle Cells Protects against Hypoxia-Mediated Pulmonary Hypertension via YAP1 SignalingJiwang Chen, Angelia Lockett, Shuangping Zhao, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 31, 2020
A novel rat model of pulmonary hypertension induced by mono treatment with SU5416Yuqin Chen, Meidan Kuang, Shiyun Liu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 17, 2016
Capsaicin-induced Ca<sup>2+</sup> signaling is enhanced via upregulated TRPV1 channels in pulmonary artery smooth muscle cells from patients with idiopathic PAHShanshan Song, Ramon J Ayon, Aya Yamamura, et al.
British Journal of Pharmacology|November 3, 2020
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in ratsChenting Zhang, Wenju Lu, Xiaoyun Luo, et al.
British Journal of Pharmacology|August 30, 2017
Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertensionKang Wu, Qian Zhang, Xiongting Wu, et al.
JACC. Basic to Translational Science|January 10, 2019
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary HypertensionHaiyang Tang, Kang Wu, Jian Wang, et al.
Biochemical Pharmacology|March 11, 2022
Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cellsJian Wang, Wenyan Liu, Wenju Lu, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2020
Altered Airway Microbiota Composition in Patients With Pulmonary HypertensionChenting Zhang, Tingting Zhang, Wenju Lu, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2014
The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertensionJiwang Chen, Haiyang Tang, Justin R Sysol, et al.
Pageof 16

Showing results (121-130 of 152) with videos related to

Sort By:
Pageof 16
Hypertension (Dallas, Tex. : 1979)|November 8, 2022
The Novel Lysosomal Autophagy Inhibitor (ROC-325) Ameliorates Experimental Pulmonary HypertensionChanglei Bao, Shuxin Liang, Ying Han, et al.
International Journal of Molecular Sciences|December 11, 2022
Sphingosine Kinase 1 Deficiency in Smooth Muscle Cells Protects against Hypoxia-Mediated Pulmonary Hypertension via YAP1 SignalingJiwang Chen, Angelia Lockett, Shuangping Zhao, et al.
Hypertension Research : Official Journal of the Japanese Society of Hypertension|May 31, 2020
A novel rat model of pulmonary hypertension induced by mono treatment with SU5416Yuqin Chen, Meidan Kuang, Shiyun Liu, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|December 17, 2016
Capsaicin-induced Ca<sup>2+</sup> signaling is enhanced via upregulated TRPV1 channels in pulmonary artery smooth muscle cells from patients with idiopathic PAHShanshan Song, Ramon J Ayon, Aya Yamamura, et al.
British Journal of Pharmacology|November 3, 2020
Mitomycin C induces pulmonary vascular endothelial-to-mesenchymal transition and pulmonary veno-occlusive disease via Smad3-dependent pathway in ratsChenting Zhang, Wenju Lu, Xiaoyun Luo, et al.
British Journal of Pharmacology|August 30, 2017
Chloroquine is a potent pulmonary vasodilator that attenuates hypoxia-induced pulmonary hypertensionKang Wu, Qian Zhang, Xiongting Wu, et al.
JACC. Basic to Translational Science|January 10, 2019
Pathogenic Role of mTORC1 and mTORC2 in Pulmonary HypertensionHaiyang Tang, Kang Wu, Jian Wang, et al.
Biochemical Pharmacology|March 11, 2022
Sodium tanshinone IIA sulfonate enhances the BMP9-BMPR2-Smad1/5/9 signaling pathway in rat pulmonary microvascular endothelial cells and human embryonic stem cell-derived endothelial cellsJian Wang, Wenyan Liu, Wenju Lu, et al.
Hypertension (Dallas, Tex. : 1979)|September 14, 2020
Altered Airway Microbiota Composition in Patients With Pulmonary HypertensionChenting Zhang, Tingting Zhang, Wenju Lu, et al.
American Journal of Respiratory and Critical Care Medicine|September 3, 2014
The sphingosine kinase 1/sphingosine-1-phosphate pathway in pulmonary arterial hypertensionJiwang Chen, Haiyang Tang, Justin R Sysol, et al.
Pageof 16